OEM/ODM NAD+ Pricing Trends and MOQ Insights
Why this matters
Health and wellness brands are increasingly looking at OEM/ODM NAD+ as a hero product for new launches. The category combines proven consumer pull, retail-ready formats, and a clear path to differentiation through formula, packaging, and brand storytelling.
This article walks through the key things buyers need to know about OEM/ODM NAD+ in 2026, from sourcing and pricing to compliance and go-to-market strategy.
What to look for in a supplier
A serious OEM/ODM partner for OEM/ODM NAD+ should provide verifiable GMP certification, an in-house R&D team, and a documented change-control process. Ask for the COA of the last three production batches and confirm that the manufacturer has third-party audit coverage from SGS, BV, or Intertek.
Equally important is responsiveness during sampling — a 7-14 day custom sample cycle is normal. If a supplier promises custom formulations in 48 hours, that is a red flag.
MOQ, pricing, and timelines
Most private label buyers can launch with an MOQ of 5,000 units. Pricing typically ranges from $2-$6 per bottle at this tier depending on formulation complexity. Mass production runs in 25-30 days after sample approval, and ocean freight from China to the US West Coast adds 18-25 days.
Regulatory and compliance notes
For the US market, ensure FDA facility registration and that the formula uses ingredients that are GRAS. For the EU, check Novel Food catalog status for newer ingredients. For the UK, Australia, and Canada, local agents can help with label compliance. A serious OEM partner will guide you through these requirements as part of the standard service package.
Go-to-market considerations
Once samples are approved and production is scheduled, focus on product photography, listing copy, and a launch landing page. For DTC, paid social and influencer seeding drive the first month of sales. For retail, prepare a sales deck with margin walk and category comparison.
The fastest path to traction is to lead with a credible formulation, transparent sourcing story, and clear category positioning — not aggressive health claims.
